Nordic Capital in €9.6bn pharma exit
Nordic Capital, a private equity firm primarily investing in Northern Europe, and co-investors have racked up nearly €10bn from the exit of Swiss drug maker Nycomed in one of Japan's...
Nordic Capital, a private equity firm primarily investing in Northern Europe, and co-investors have racked up nearly €10bn from the exit of Swiss drug maker Nycomed in one of Japan's...